Growth Metrics

Lemaitre Vascular (LMAT) Equity Ratio (2016 - 2025)

Lemaitre Vascular (LMAT) has disclosed Equity Ratio for 16 consecutive years, with 0.64 as the latest value for Q4 2025.

  • On a quarterly basis, Equity Ratio rose 4.57% to 0.64 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.64, a 4.57% increase, with the full-year FY2025 number at 0.64, up 4.57% from a year prior.
  • Equity Ratio was 0.64 for Q4 2025 at Lemaitre Vascular, up from 0.63 in the prior quarter.
  • In the past five years, Equity Ratio ranged from a high of 0.88 in Q1 2022 to a low of 0.61 in Q4 2024.
  • A 5-year average of 0.8 and a median of 0.86 in 2022 define the central range for Equity Ratio.
  • Peak YoY movement for Equity Ratio: skyrocketed 39.79% in 2021, then decreased 28.85% in 2024.
  • Lemaitre Vascular's Equity Ratio stood at 0.87 in 2021, then fell by 0.48% to 0.86 in 2022, then decreased by 0.55% to 0.86 in 2023, then fell by 28.85% to 0.61 in 2024, then rose by 4.57% to 0.64 in 2025.
  • Per Business Quant, the three most recent readings for LMAT's Equity Ratio are 0.64 (Q4 2025), 0.63 (Q3 2025), and 0.63 (Q2 2025).